M-1673

N/A

Report date: 2025/01/26 18:44:30

Base Information

Drug NameM-1673
Drug Alias NameGDF5 mutant (Merck KGaA)M-1673
ClassificationBiologics
Mechanisms of ActionGrowth/differentiation factor 5 modulators
TargetsGrowth/differentiation factor 5
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A